Biostage, Inc. (BSTG) は上場企業です ヘルスケア セクターの バイオテクノロジー 業界で事業展開. 本社所在地は Holliston, MA, アメリカ. 現CEOは Junli He.
BSTG を有する IPO日 2013-10-21, 7 名の正社員, に上場 Other OTC, 時価総額 $57.82M.
Biostage, Inc., a biotechnology company, offers products to cure patients of cancers, injuries, and birth defects of the gastro-intestinal tract and the airways. The company is engaged in developing Biostage Esophageal Implant for the treating esophageal cancer. The company was formerly known as Harvard Apparatus Regenerative Technology, Inc. and changed its name to Biostage, Inc. in March 2016. Biostage, Inc. was founded in 2009 and is headquartered in Holliston, Massachusetts.
